Results 331 to 340 of about 191,621 (404)

Seizure and Takotsubo cardiomyopathy due to Proton pump inhibitor

Indira Acharya, Ashik Pokharel, Daniel Grove, Christopher Haas   +3 more
openalex   +2 more sources

Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: prognostic effect of proton pump inhibitor use. [PDF]

Oncologist
Chen BF, Lai JI, Tsai YF, Lien PJ, Lin YS, Feng CJ, Chen YJ, Cheng HF, Chao TC, Liu CY, Tseng LM, Huang CC.   +11 more
europepmc   +1 more source

Budget Impact Analysis of Stepping Down Patients from Long-Term Inappropriate Proton Pump Inhibitor Use to Episodic Alginate Treatment: NHS England Perspective. [PDF]

J Health Econ Outcomes Res
Wray J, Aluko P, Sharma Y, Horvath E, Panchal M, Guerra I, Stevens R, Coyle C, Plehhova K.   +8 more
europepmc   +1 more source

Mechanistic Insights Into Photocatalytic Materials for Toxic Pollutants: Environmental Remediation of Personal Care Products

Asia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Photocatalytic materials have emerged as promising solutions for environmental applications due to their ability to degrade organic pollutants under sunlight or artificial light. In this review, recent progress on the photocatalytic materials used for the degradation of pharmaceutical personal care products (PPCPs) in environmental ...
Urvashi Sen, Gunjan Chauhan, Surbhi Soni, Monika Vats, Anand Kumar, Indra Bahadur   +5 more
wiley   +1 more source

Association between proton pump inhibitor use and the risk of myocardial infarction: A cross-sectional study based on NHANES 2007 to 2018. [PDF]

Medicine (Baltimore)
Zhang W, Yuan Z, Zhou J.
europepmc   +1 more source

Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

Arthritis &Rheumatology, EarlyView.
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman, Voon Ong, Christopher P. Denton   +2 more
wiley   +1 more source

Time to halt the overprescribing of proton pump inhibitors [PDF]

, 2016
Marks, DJB
core  

Visibility Evaluation of Fundic Gland Polyp Associated With Proton Pump Inhibitor in Texture and Color Enhancement Imaging. [PDF]

DEN Open
Uchida R, Ueyama H, Takeda T, Nakamura S, Uemura Y, Iwano T, Yamamoto M, Utsunomiya H, Abe D, Oki S, Suzuki N, Ikeda A, Akazawa Y, Ueda K, Hojo M, Nojiri S, Yao T, Nagahara A.   +17 more
europepmc   +1 more source

A New Era for Using Natural Pigments: The Case of the C50 Carotenoid Called Bacterioruberin

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Haloarchaea are extremophilic microorganisms belonging to the Archaea domain that require high salt concentrations to live, thus inhabiting ecosystems like salty ponds, salty marshes, or extremely salty lagoons. They are more abundant and widely distributed worldwide than initially expected.
Micaela Giani, Elena Valdés, José María Miralles‐Robledillo, Guillermo Martínez, Carmen Pire, Rosa María Martínez‐Espinosa   +5 more
wiley   +1 more source

Association between preoperative proton pump inhibitor use and postoperative infectious and renal complications following major elective surgery. [PDF]

Can J Surg
Dubois L, McClure JA, Jones PM, Mrkobrada M, Flier S, Welk B, Vogt K.   +6 more
europepmc   +1 more source